Upgrade to SI Premium - Free Trial

CFRA Upgrades Quest Diagnostics (DGX) to Buy

October 22, 2024 12:20 PM
CFRA analyst Paige Meyer upgraded Quest Diagnostics (NYSE: DGX) from Hold to Buy with a price target of $178.00 (from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Upgrades

Next Articles